Kailera Therapeutics, Inc. (KLRA)

15.74 -0.11 (-0.69%) USD  |  NASDAQ  |  Sep 03, 16:00
15.97 +0.23 (+1.46%) After-Hours: 05:52
More

Kailera Therapeutics Cash and Short Term Investments (Quarterly) : 916.74M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 916.74M
Date Value
March 31, 2026 519.17M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Moderna, Inc. 5.138B
Revolution Medicines, Inc. 3.938B
Sana Biotechnology, Inc. 164.68M
Parabilis Medicines, Inc. 1.121B
Arrowhead Pharmaceuticals, Inc. 1.602B